Thor Medical Share Price

NANOV

NO0010597883

Biotechnology & Medical Research

Real-time Oslo Bors 11:41:08 10/09/2026 BST			5-day change	1st Jan Change
4.820 ^NOK	+0.94%		-12.52%	-8.86%

08-28	Thor Medical ASA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-28	Thor Medical ASA, H1 2026 Earnings Call, Aug 28, 2026

Last Transcript : Thor Medical

Thor Medical ASA, H1 2026 Earnings Call, Aug 28, 2026

08-28

More transcripts

News in other languages : Thor Medical

08-20	Avis d'analystes du jour : ça bouge sur Michelin, Sartorius, Pandora et Merck KGaA
02/06/22	Actualización de las fuertes variaciones del día: EcoOnline despierta su sector, Klöckner ajuste después de dividendo
02/06/22	Point sur les fortes variations du jour : Saint-Gobain réveille son secteur, Esker trop prudent
19/02/21	Avis d'analystes du jour : L'Oréal, Air France KLM, Nestlé, Orange, Campari, Moncler, BioMérieux, Stratec...
19/02/21	Des PMI et des sorcières pour terminer la semaine

More news

Managers and Directors : Thor Medical

Manager	Title	Age	Since
Jasper Kurth CEO	Chief Executive Officer	41	31/07/2024
Brede Høyland Ellingsæter DFI	Director of Finance/CFO	37	30/06/2023
Sindre Hassfjell CTO	Chief Tech/Sci/R&D Officer	-	31/05/2023

Director	Title	Age	Since
Mimi Kristine Berdal BRD	Director/Board Member	67	27/06/2023
John Andersen CHM	Chairman	59	-
Jens Gisle Schnelle BRD	Director/Board Member	-	23/04/2025

More insiders

Thor Medical ASA, formerly Nordic Nanovector ASA, is a Norway-based biopharmaceutical company. The Company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. The Company has developed a proprietary technology for the manufacturing of radionuclides, primarily alpha-particle emitters from natural resources. The high energy deposition and the short range of alpha particles make it possible to eradicate cancer cells while minimizing damage to nearby healthy cells

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
10/09/26	NOK 4.820	+0.94%	2,965,053
09/09/26	NOK 4.775	-6.00%	9,808,493
08/09/26	NOK 5.080	+5.07%	11,112,380
07/09/26	NOK 4.835	-0.92%	7,436,212
04/09/26	NOK 4.880	-10.79%	88,159,998

Real-time Oslo Bors

More quotes

Analysts' Consensus

Sell

Buy

Mean consensus

SELL

Number of Analysts

Last Close Price

4.775NOK

Average target price

4.200NOK

Spread / Average Target

-12.04%

Consensus

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Market Cap	2.02B 219M 189M 178M 162M 303M 20.85B 304M 2.1B 813M 10.62B 823M 805M 33.66B	P/E 2026 *	-23.9x	P/E 2027 *	-39.8x
Enterprise Value	2.21B 241M 207M 195M 178M 332M 22.89B 334M 2.31B 893M 11.66B 903M 884M 36.95B	EV / Sales 2026 *	111x	EV / Sales 2027 *	15.3x
Free-Float	58.79%	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
Oslo Bors	NANOV	Real-time
CBOE	NANOo	Real-time
London S.E.	0R6Y	End-of-day quote
Nasdaq Stockholm	NANOVO	Delayed
Tradegate	8NN	Real-time
Deutsche Boerse AG	8NN	Delayed
London S.E.	0R6Y	Delayed
CBOE	0R6Y	Real-time
Börse Stuttgart	8NN	Delayed
Boerse Muenchen	8NN	Real-time
Berne S.E.	8NN	End-of-day quote

08-28	Thor Medical ASA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-28	Thor Medical ASA, H1 2026 Earnings Call, Aug 28, 2026
08-25	Thor Medical's COO, CFO Transitions to Dedicated COO Role	MT
08-25	Thor Medical Asa CFO Brede Ellingsæter to Transition into Full-Time COO Role	CI
08-19	Thor Medical Asa Alphaone Facility Officially Opened by Norwegian Prime Minister Jonas Gahr Støre	CI
08-05	Thor Medical Completes Maiden Thorium-228 Isotope Delivery from AlphaOne Plant	MT
08-05	Thor Medical Asa Completes First Customer Delivery from Alphaone Production Facility	CI
07-31	Thor Medical ASA Starts Commercial Production At AlphaOne Facility	CI
06-16	Thor Medical ASA Announces Retirement of Alf Bjørseth from EVP Business Development, Effective June 30, 2026	CI
05-29	Thor Medical ASA Enters Collaboration and Supply Agreement With Minerva Imaging	CI
05-29	Thor Medical Lands Deal to Supply Cancer Treatment Isotope	MT
05-29	Thor Medical enters partnership agreement with Minerva Imaging	RE
05-28	Thor Medical, Eckert & Ziegler Close Deal for Lead-212 Supply	MT

09:36am	Thor Medical ASA: Primary Insider Notification in Relation to Redelivery of Shares	PU
09:32am	Thor Medical ASA: Disclosure of Large Shareholding	PU
09:32am	Thor Medical : Share Capital Increase in Relation to the Private Placement and the Retail Offering is Registered	PU
08-28	Thor Medical ASA: First Half 2026 Results – AlphaOne Operational, Entering Commercial Ramp-Up	PU
08-25	Thor Medical ASA: Strengthening Executive Management Following AlphaOne Start-Up	PU

1 day	+0.21%
1 week	-12.52%
Current month	-15.76%
1 month	-18.34%
3 months	+19.03%
6 months	+9.75%
Current year	-8.86%

Thor Medical Share Price

Stocks

NANOV

NO0010597883

Biotechnology & Medical Research

Valuation : Thor Medical

Chart: Thor Medical

Latest news : Thor Medical

Last Transcript : Thor Medical

Press Releases : Thor Medical

News in other languages : Thor Medical

Quotes and Performance

Price Extremes

Managers and Directors : Thor Medical

Latest insider transactions

Bio Therapeutic Drugs

Financials

Company Profile

Quotes

Analysts' Consensus

Annual profits - Rate of surprise

1 week	4.74	5.14
1 month	4.74	7.12
Current year	3.88	7.12
1 year	3.18	7.12
3 years	0.85	7.12
5 years	0.85	7.12
10 years	0.85	7.12

Date	Insider	Type	Main position	Quantity	% Market Cap.
26/06/25	Scatec Innovation AS	Others	Company	31,577,399	10.0434%
18/06/25	Scatec Innovation AS	Buy	Company	3,000,000	0.9542%
02/05/25	Jens Gisle Schnelle	Exercice	Director	164,641	0.0524%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THOR MEDICAL	+0.94%	-12.52%	+23.96%	+268.08%	219M
WUXI APPTEC CO., LTD.	-0.94%	-0.71%	+45.60%	+103.25%	68.52B
ARGENX SE	-0.39%	-5.50%	+31.47%	+75.35%	62.88B
INSMED INCORPORATED	+3.13%	+1.71%	-12.50%	+390.48%	28.13B
WUXI BIOLOGICS (CAYMAN) INC.	-2.74%	-6.55%	+26.01%	+10.96%	25.56B
BIONTECH SE	-0.54%	-5.47%	-3.88%	-18.31%	24.65B
GENMAB A/S	-1.31%	-4.05%	+19.16%	-18.67%	19.81B
PHARMAESSENTIA CORPORATION	-4.27%	+3.07%	+211.22%	+362.48%	17.69B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-1.37%	-4.71%	-5.41%	+506.15%	14.66B
EXELIXIS, INC.	+1.14%	-0.34%	+52.38%	+163.82%	14.45B
Average	-0.72%	-2.86%	+38.80%	+184.36%	27.66B
Weighted average by Cap.	-0.69%	-1.88%	+36.59%	+139.26%

	2026 *	2027 *
Net sales	20M 2.17M 1.87M 1.76M 1.6M 3M 207M 3.01M 20.86M 8.06M 105M 8.16M 7.98M 334M	145M 15.75M 13.55M 12.76M 11.63M 21.76M 1.5B 21.85M 151M 58.46M 764M 59.15M 57.86M 2.42B
Net income	-70M -7.6M -6.54M -6.16M -5.61M -10.5M -724M -10.55M -73.02M -28.22M -369M -28.55M -27.93M -1.17B	-44M -4.78M -4.11M -3.87M -3.53M -6.6M -455M -6.63M -45.9M -17.74M -232M -17.95M -17.56M -734M
Net Debt	197M 21.4M 18.42M 17.34M 15.8M 29.56M 2.04B 29.68M 206M 79.43M 1.04B 80.36M 78.62M 3.29B	201M 21.84M 18.79M 17.69M 16.12M 30.16M 2.08B 30.28M 210M 81.04M 1.06B 81.99M 80.21M 3.35B